Blackstone
Amicus Seals $430M Financing from Blackstone Post-Pompe Disease Drug Approval
Anika Sharma
Fresh from securing FDA approval for its combination treatment targeting Pompe disease, Amicus Therapeutics has attracted a significant investment. Amicus ...
